“…Aptamers, obtained through the systematic evolution of ligands by exponential enrichment (SELEX) screening, are single-stranded DNA or RNA molecules that can bind tightly and specifically to target molecules. − Aptamer-based biosensors, which exhibit high sensitivity and simplicity, have been extensively developed to detect disease markers, including electrochemical, − localized surface plasmon resonance, and fluorescence sensors. , In 2017, Gu’s group developed the 25(OH)VD3 aptamers by SELEX, and the dissociation constants ( K d ) of the aptamer VDBA14 were determined to be 11 nM . Inspired by these encouraging developments, researchers are now focusing on developing more sensitive and reliable detection methods that allow the monitoring of 25(OH)VD3 biotransformation in cells. , However, using aptamer-based assays for detecting 25(OH)VD3 in living cells has limitations, including uneven distribution and inconsistent spatial orientation during immobilization, as well as impaired binding epitopes due to steric hindrance and random orientation. − Increasing immobilized aptamer numbers can help, but high density can lead to hindrance. Therefore, new methods are still needed for monitoring 25(OH)VD3 metabolism in living cells with improved sensitivity and accuracy.…”